Scholarlink

<p>This study investigated the anti-obesity potential of <i>Lactococcus lactis</i> engineered to constitutively secrete P9 (Amuc_1631), a protein from <i>Akkermansia muciniphila</i>. Our findings show that the engineered strain <i>L. lactis</i> P11P9 effectively secretes P9 and significantly increases GLP-1 production in NCI-H716 enteroendocrine cells, with a 2.65-fold rise compared to controls. In high-fat diet (HFD)-induced obese mice, oral administration of <i>L. lactis</i> P11P9 resulted in reduced weight gain, decreased food intake, and attenuation of adipocyte hypertrophy. ELISA analysis of serum samples indicated that <i>L. lactis</i> P11P9 treatment elevated circulating GLP-1 levels. RT-qPCR analysis further revealed increased expression of GLP-1 synthesis-related genes (e.g., <i>GCG</i> and <i>PCSK1</i>) in intestinal tissues. In addition, transcription of thermogenesis-associated genes such as <i>UCP1</i> and <i>PGC-1α</i> was upregulated in adipose tissue. Taken together, this study suggests that engineered <i>L. lactis</i> P11P9 helps reduce obesity by increasing GLP-1 secretion and stimulating thermogenesis, providing a promising strategy for obesity treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Engineered Lactococcus lactis secreting a glucagon-like peptide-1-inducing protein P9 for amelioration of obesity in mice

  • 期刊论文

  • 发表日期：

    2025年8月15日

查看全文
  • Wenxuan Di,
  • Xiaoyue Bai,
  • Shuangrui Tian,
  • Liang Zhao,
  • Xi Cao,
  • Yanling Hao,
  • Zhengyuan Zhai

摘要

This study investigated the anti-obesity potential of Lactococcus lactis engineered to constitutively secrete P9 (Amuc_1631), a protein from Akkermansia muciniphila. Our findings show that the engineered strain L. lactis P11P9 effectively secretes P9 and significantly increases GLP-1 production in NCI-H716 enteroendocrine cells, with a 2.65-fold rise compared to controls. In high-fat diet (HFD)-induced obese mice, oral administration of L. lactis P11P9 resulted in reduced weight gain, decreased food intake, and attenuation of adipocyte hypertrophy. ELISA analysis of serum samples indicated that L. lactis P11P9 treatment elevated circulating GLP-1 levels. RT-qPCR analysis further revealed increased expression of GLP-1 synthesis-related genes (e.g., GCG and PCSK1) in intestinal tissues. In addition, transcription of thermogenesis-associated genes such as UCP1 and PGC-1α was upregulated in adipose tissue. Taken together, this study suggests that engineered L. lactis P11P9 helps reduce obesity by increasing GLP-1 secretion and stimulating thermogenesis, providing a promising strategy for obesity treatment.